US 7018986
Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption
expired A61KA61K31/592A61K31/715
Quick answer
US patent 7018986 (Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption) held by Immudyne, Inc. expires Mon Mar 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Immudyne, Inc.
- Grant date
- Tue Mar 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 46
- CPC classes
- A61K, A61K31/592, A61K31/715, A61K33/06, A61K33/16